AccessLifeNetHealth

Phone: 888.847.7831

Cardiac

Cardiac Image

Allograft Bio-Implants for Cardiac Procedures

Suitable for a wide variety of complex congential heart defects, as well as for adults with extensive valvular disease. The CardioGraft® line of tissue grafts offers heart valves, repair grafts, conduits and decellularized tissue grafts with MATRACELL® decellularization technology.

To download or print our full line of allograft bio‑implants click here.

« Back to Home

Conduits

Ascending Aorta (non-valved)
Download PDF
Ascending Aorta (non-valved) Image 1

Description

Ascending Aorta non-valved

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Conduit repair

Features and Benefits

  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
  • No anticoagulation therapy required
Cryopreserved Description Size
AAL Ascending Aorta (non-valved) D = 22 mm and greater
AAM Ascending Aorta (non-valved) D = 17 to 21 mm
AAS Ascending Aorta (non-valved) D = 16 mm and less
Pulmonary Artery (non-valved)
Download PDF
Pulmonary Artery (non-valved) Image 1

Description

Non-Valved Pulmonary Artery

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Right side/pulmonary reconstructions
  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus
  • Pulmonary root stenosis

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
PAL Pulmonary Artery (non-valved) D = 22 mm and greater
PAM Pulmonary Artery (non-valved) D = 17 - 21 mm
PAS Pulmonary Artery (non-valved) D = 16 mm and less
Thoracic Aorta
Download PDF
Thoracic Aorta Image 1

Description

Thoracic Aorta

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Infected descending aorta  
  • Conduit repair
  • Extra-cardiac shunt
     

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
TAL Thoracic Aorta D = 22 mm and greater
TAM Thoracic Aorta D = 17 to 21 mm
TAS Thoracic Aorta D = 16 mm and less

Repair Grafts

Decellularized Hemi-Pulmonary Artery
Download PDF
Decellularized Hemi-Pulmonary Artery Image 1

Description

Decellularized Hemi-Pulmonary Artery with Matracell™

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • RVOT Repair

Features and Benefits

Matracell safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant.

Alternative Products

Decellularized Hemi-Pulmonary Artery with Matracell

Frozen Description Size
DLHPA Left Hemi-Pulmonary Artery (decellularized) Left
DRHPA Right Hemi-Pulmonary Artery (decellularized) Right
Decellularized Pulmonary Patch
Download PDF
Decellularized Pulmonary Patch Image 1

Description

Decellularized pulmonary patch with Matracell™.

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • RVOT Repair
Frozen Description Size
DPPGK Thick Pulmonary Patch (decellularized) W = 25-50 mm in 5 mm increments; L = 30-60 mm in 5 mm increments
DPPGN Thin Pulmonary Patch (decellularized) W = 25-50 mm in 5 mm increments; L = 30-60 mm in 5 mm increments
Hemi-Pulmonary Artery
Download PDF
Hemi-Pulmonary Artery Image 1

Description

Hemi-Pulmonary Artery

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus
  • Transposition of great vessels 
  • Hypoplastic left heart (modified Fontan)
  • Aortic stenosis/atresia
     

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
LHPA Left Hemi-Pulmonary Artery Varies
RHPA Right Hemi-Pulmonary Artery Varies
Mono Cusp Patch
Download PDF
Mono Cusp Patch Image 1

Description

Mono Cusp Patch

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Tetralogy of Fallot
  • RVOT/root enlargement procedures

Features and Benefits

  • Single valved section of main pulmonary trunk
  • Original annulus diameter
  • Length and width measured in centimeters
  • No minimum or maximum width
Cryopreserved Description Size
LMCP Left Mono Cusp Patch W/L Varies
MCP Mono Cusp Patch 1.0 cm or greater of conduit to the distal commissure
RMCP Right Mono Cusp Patch W/L Varies
Pulmonary Patch
Download PDF
Pulmonary Patch Image 1

Description

Pulmonary patch section produced from the main pulmonary artery.

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Right side/pulmonary reconstructions
  • Tetralogy of Fallot
  • Single ventricle/double outlet (Fontan)
  • Truncus arterious; ASD/VSD repair

Features and Benefits

  • No anticoagulation therapy required
  • Non-thromogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
PPGK Thick Pulmonary Patch W = 25-50 mm in 5 mm increments; L = 30-60 mm in 5 mm increments
PPGN Thin Pulmonary Patch W = 25-50 mm in 5 mm increments; L = 30-60 mm in 5 mm increments

Valves

Aortic Heart Valve
Download PDF
Aortic Heart Valve Image 1

Description

Aortic Heart Valve

Franchises

Cardiac

Brand

CardioGRAFT® - this is what is under the Brand Tab

Clinical Application

  • Left side/aortic reconstruction
  • Aortic stenosis/atresia
  • Hypoplastic left heart
  • Repair of RVOTs (Right Ventricular Outflow Tract)

Features and Benefits

  • No anticoagulation therapy required
  • Exceptionally good hemodynamic performance
  • No immunosuppressive therapy needed
  • Non-thrombogenic
  • Non-hemolytic
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
HVAL Aortic Heart Valve D = 22 mm and greater
HVAM Aortic Heart Valve D = 17 - 21 mm
HVAS Aortic Heart Valve D = 16 mm and less
Pulmonary Heart Valve
Download PDF
Pulmonary Heart Valve Image 1

Description

Pulmonary Heart Valve

Franchises

Cardiac

Brand

CardioGRAFT®

Clinical Application

  • Right side/pulmonary reconstructions
  • Hypoplastic left heart (modified Fontan)
  • Ross procedure
  • Truncus arteriosus
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Pulmonary root stenosis

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Cryopreserved Description Size
HVPL Pulmonary Heart Valve D = 22 mm and greater
HVPM Pulmonary Heart Valve D = 17 - 21 mm
HVPS Pulmonary Heart Valve D = 16 mm and less


LifeLines Newsletter

Links to our Newsletter Archive Focus on SafetyDecember 2011
 Focus on SafetyFocus on Safety
 Focus On Safety
 Issue 019Issue 019
 Focus on QualityFocus on Quality
 Focus on QualityDecember 2011
 Focus on InnovationDecember 2011
 Focus on InnovationFocus on Innovation
 Issue 018December 2011
 Focus on ServiceFocus on Service













  11. Enter the text as it appears on the image

X